Off-patent liver disease drug could prevent coronavirus infection...

" The research, published today in Nature, showed that an existing drug used to treat a type of liver disease is able to "lock" the doorway by which SARS-CoV-2 enters our cells, a receptor on the cell surface known as ACE2. Because this drug targets the host cells and not the virus, it should protect against future new variants of the virus as well as other coronaviruses that might emerge. "

https://medicalxpress.com/news/2022-12-off-patent-liver-disease-drug-covid-.html